A preliminary estimate, and a request for better ones.
Summary
I believe the standard literature estimates for the number of DALYs attributable to a case of stunting are too low, largely because they don’t account for the long term effects. This means that childhood nutritional interventions that reduce the prevalence of stunting may be substantially more cost-effective than previously believed.
Epistemic status
Exploratory and back-o...
Note: This post was crossposted from Planned Obsolescence by the Forum team, with the author's permission. The author may not see or respond to comments on this post.
Subtitle: It’s a major warning shot, and might be the last one we get
All opinions are my personal view, and don’t represent my employer or fellow investigators.
This week, METR and Redwood Research published...
Last week, the Forum grappled with cluelessness. The volume of entries (76 essays!)[1]—from newcomers...
Zero-bounded vs negative-tail risks
(adapted from a comment on LessWrong)
In light of the FTX thing, maybe a particularly important heuristic is to notice cases where the worst-case is not lower-bounded at zero. Examples:
Not that you should definitely not do things that potentially have large-negative downsides, but you can be a lot more willing to experiment when the downside is capped at zero.
Indeed, a good norm in many circumstances is to do lots of exploration and iteration. This is how science, software development, and most research happens. Things get a lot tricker when even this stage has potential deep harms -- as in research with advanced AI. (Or, more boundedly & fixably, infohazard risks from x- and s-risk reduction research.)
In practice, people will argue about what counts as effectively zero harm, vs nonzero. Human psychology, culture, and institutions are sticky, so exploration that naively looks zero-bounded can have harm potential via locking in bad ideas or norms. I think that harm is often fairly small, but it might be both important and nontrivial to notice when it's large -- e.g., which new drugs are safe to explore for a particular person? caffeine vs SSRIs vs weed vs alcohol vs opioids...
(Note that the "zero point" I'm talking about here is an outcome where you've added zero value to the world. I'm thinking of the opportunity cost of the time or money you invested as a separate term.)